Carboxylesterases (CEs) are nonspecific hydrolytic enzymes and responsible for the metabolism of xenobiotics and endobiotics that contain ester bonds. There are two human CE isoforms found in liver, CES1 and CES2. In this study it is shown that the mere abundance of CES1 protein expression in human liver does not predict its biochemical activity. The human interindividual variation in CES1 activities may attribute to several mechanisms. One possibility is the presence of endogenous inhibitors in liver, arachidonic acid (AA) and 27-hydroxycholesterol (27-HC). CES1 is also expressed in human monocytes/macrophages and is proposed to catalyze the rate-limiting step of cholesterol ester mobilization in macrophages. It is of interest to determine whether CES1 can degrade the lipid mediators, 2-arachidonoylglycerol (2-AG), prostaglandin E2-1-glyceryl ester (PGE2-G), and prostaglandin F2α-1-glyceryl ester (PGF2α-G), in monocytes/macrophages and to determine if this metabolism is inhibited by organophosphate pesticide exposure.

No description available.

Evidence suggests that pesticide exposure is a risk factor for atherosclerosis, a pathology involving oxidative stress and dysregulated cholesterol metabolism in monocytes and macrophages as vital causative factors. This research focused on understanding two different mechanisms by which organochlorine and organophosphate pesticides may contribute to atherogenesis. First, the ability of organochlorine insecticides to contribute to elevated oxidative stress was investigated. Urinary concentrations of F2-isoprostanes (a systemic oxidative stress biomarker) and serum levels of the persistent organochlorine compounds p,p’-DDE, trans-nonachlor and oxychlordane were quantified in human samples and the association of these factors with diagnosis of atherosclerosis was described in a cross-sectional study. Subsequently, the ability of three bioaccumulative organochlorine insecticides, trans-nonachlor, dieldrin and p,p’-DDE, to induce the production of superoxide radical anion via NADPH oxidase activation in cultured human THP-1 monocytes through a phospholipase A2 (PLA2)-derived arachidonic acid (AA) signaling cascade was investigated. Trans-nonachlor induced NOX-dependent generation of superoxide/ROS (as measured using three distinct assay types) and stimulated the phosphorylation and membrane translocation of the p47phox regulatory subunit (two biomarkers of Nox activation). Measurement of arachidonic acid and eicosanoid release from OC-exposed monocytes by LC-MS/MS analysis subsequently confirmed the role of PLA2 as a central signaling node in the induction of reactive oxygen production in this process. To investigate a separate mechanism by which organophosphate toxicity may contribute to atherosclerosis, the ability of the esterase/lipase carboxylesterase 1 (CES1), a major enzyme target of OP toxicants, to regulate endocannabinoid and cholesterol homeostasis in human macrophages was assessed. Experimental ablation of CES1 activity altered cholesterol uptake, but not efflux in macrophage foam cells in vitro. Numerous genes involved in the cholesterol homeostatic process, including scavenger receptors (SR-A, CD36), cholesterol transporters (ABCA1, ABCG1), nuclear receptors (LXR, PPAR) and oxysterol forming enzymes (CYP27A1), were profoundly downregulated in CES1 knockdown cells. CES1 appears to play a broad central role in both normal macrophage physiology and the homeostatic response to modified LDL, potentially by liberating esterified molecules from lipoprotein particles that serve as ligands for transcription factors such as PPAR and LXR that control the expression of genes critical to the cholesterol metabolic process.